Dr. Adam Konopka, PhD
Claim this profileUniversity of Wisconsin-Madison
Studies Aging
Studies Insulin Resistance
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Adam Konopka, PhD is currently running
Everolimus
for Aging
This trial is testing whether the drug everolimus can safely improve health and slow aging in adults aged 55-80 who are insulin resistant or prediabetic. Everolimus works by blocking a protein involved in cell growth and aging. The study aims to see if this can help improve various aspects of health without serious side effects. Everolimus has been studied for various conditions, including cancer and organ transplantation.
Recruiting0 awards Phase 210 criteria
Rapalogs
for Aging
The objective of RAP PAC is to identify safe and effective weekly dose(s) for the mTOR inhibitors sirolimus and everolimus that intervene on the underlying fundamental biology of aging. Participants who are 55-89 years old that are free of overt chronic diseases will be assigned to either 6 weeks of sirolimus or everolimus (5 mg, 10 mg, or 15 mg once per week). The investigators will complete the everolimus arm first and then subsequently complete the sirolimus arm of the study. Total time on study would be up to 17 weeks to complete baseline and follow up visits.
Recruiting1 award Phase 1
More about Adam Konopka, PhD
Clinical Trial Related5 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Adam Konopka, PhD has experience with
- Everolimus
- Sirolimus
- Metformin
- Placebo Oral Tablet
Breakdown of trials Adam Konopka, PhD has run
Insulin Resistance
Chronic Disease
Mitochondria
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adam Konopka, PhD specialize in?
Adam Konopka, PhD focuses on Aging and Insulin Resistance. In particular, much of their work with Aging has involved treating patients, or patients who are undergoing treatment.
Is Adam Konopka, PhD currently recruiting for clinical trials?
Yes, Adam Konopka, PhD is currently recruiting for 2 clinical trials in Madison Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Adam Konopka, PhD has studied deeply?
Yes, Adam Konopka, PhD has studied treatments such as Everolimus, Sirolimus, Metformin.
What is the best way to schedule an appointment with Adam Konopka, PhD?
Apply for one of the trials that Adam Konopka, PhD is conducting.
What is the office address of Adam Konopka, PhD?
The office of Adam Konopka, PhD is located at: University of Wisconsin-Madison, Madison, Wisconsin 53705 United States. This is the address for their practice at the University of Wisconsin-Madison.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.